Vascular comorbidities in familial Mediterranean fever

Rheumatology International

Volumn 31, Issue 10, 2011, Pages 1275-1281

  Özçakar, Z Birsin ^a   Yalçınkaya, Fatoş ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Amyloidosis; Atherosclerosis; Comorbidities; Familial Mediterranean fever; Vasculitis

Indexed keywords

C REACTIVE PROTEIN; COLCHICINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLIXIMAB; INTERFERON; THALIDOMIDE;

AMYLOIDOSIS; ANAPHYLACTOID PURPURA; ARTHRITIS; ATHEROSCLEROSIS; BEHCET DISEASE; COMORBIDITY; DISEASE ASSOCIATION; FAMILIAL MEDITERRANEAN FEVER; GENE MUTATION; GENOTYPE; HEART AMYLOIDOSIS; HEART INFARCTION; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; POLYARTERITIS NODOSA; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE; VASCULITIS;

EID: 80054952422     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1845-7     Document Type: Review

References (74)

1. M Lidar A Livneh 2007 Familial Mediterranean fever: clinical, molecular and management advancements Neth J Med 65 318 324 17954950 1:CAS:528: DC%2BD2sXhtleltr3J (Pubitemid 350011355)
2. HS Heller L Sherf 1958 Familial Mediterranean fever (FMF) Arch Intern Med 102 50 71 1:STN:280:DyaG1c7gtFyjsg%3D%3D
3. I Touitou T Sarkisian M Medlej-Hashim, et al. 2007 Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever Arthritis Rheum 56 1706 1712 17469185 10.1002/art.22507 (Pubitemid 46764102)
4. Kastner DL, Aksentijevich I (2005) Arthritis and Allied Conditions. Lippincott, Williams & Wilkins, MD
5. Mamou H, Cattan R. La maladie periodique (sur 14 cas personnels dont 8 compliques de nephropathies) (1952) Sem Hop Paris 28:1062-1070
6. SE Goldfinger 1972 Colchicine for familial Mediterranean fever N Engl J Med 287 1302 4636899 1:STN:280:DyaE3s%2FkvF2gtA%3D%3D
7. Özkan E, Oku O, Ekmekçi A, Ozcan R, Tag T (1972) A new approach to the treatment of periodic fever. Med Bull İstanbul pp 44-49
8. M Centola G Wood DM Frucht, et al. 2000 The gene for familial Mediterranean fever, MEFV, is expressed in early leucocyte development and is regulated in response to inflammatory mediators Blood 95 3223 3231 10807793 1:CAS:528:DC%2BD3cXjt1Cjs7o%3D (Pubitemid 30321178)
9. JJ Chae I Aksentijevich DL Kastner 2009 Advances in the understanding of familial Mediterranean fever and possibilities for targeted therapy Br J Haematol 146 467 478 19466978 10.1111/j.1365-2141.2009.07733.x 1:CAS:528:DC%2BD1MXhtFeqtLvF
10. E Ben-Chetrit M Levy 1998 Familial Mediterranean fever Lancet 351 659 664 9500348 10.1016/S0140-6736(97)09408-7 1:STN:280:DyaK1c7lvF2rtg%3D%3D (Pubitemid 28098460)
11. F Onen 2006 Familial Mediterranean fever Rheumatol Int 26 489 496 16283319 10.1007/s00296-005-0074-3
12. HJ Lachman B Şengül TU Yavuzşen, et al. 2006 Clinical and subclinical inflammation in patients with familial Mediterranean fever and heterozygous carriers of MEFV mutations Rheumatology 45 746 750 10.1093/rheumatology/kei279 (Pubitemid 43985345)
13. C Korkmaz H Özdoǧan Ö Kasapçopur H YazIcI 2002 Acute phase esponse in familial Mediterranean fever Ann Rheum Dis 61 79 81 11779767 10.1136/ard.61.1.79 1:STN:280:DC%2BD38%2FltlGrtw%3D%3D (Pubitemid 34074848)
14. AY Gasparyan M Ugurlucan 2008 The emerging issue of cardiovascular involvement in familial Mediterranean fever Arch Med Sci 4 465 467
15. M Tunca S Akar F Onen, et al. 2005 Familial Mediterranean fever (FMF) in Turkey: results of nationwide multicenter study Medicine 84 1 11 15643295 10.1097/01.md.0000152370.84628.0c (Pubitemid 40130180)
16. H Özdoǧan N ArIsoy Ö Kasapçopur, et al. 1997 Vasculitis in familial Mediterranean fever J Rheumatol 24 323 327 9034991 (Pubitemid 27104097)
17. I Touitou X Magne N Molinari, et al. 2000 MEFV mutation in Behçet's disease Hum Mutat 16 271 272 10980540 10.1002/1098-1004(200009) 16:3<271::AID-HUMU16>3.0.CO;2-A 1:STN:280:DC%2BD3M%2Fht1KntA%3D%3D
18. P Atagündüz T Ergun H Direskeneli 2003 MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvement Clin Exp Rheumatol 21 4 Suppl 30 35 37
19. E Rabinovich Y Shinar M Leiba M Ehrenfeld P Langevitz A Livneh 2007 Common FMF alleles may pedispose to development of Behçet's disease with increased risk for venous thrombosis Scand J Rheumatol 36 48 52 17454935 10.1080/03009740600759639 1:CAS:528:DC%2BD2sXltFWis7Y%3D (Pubitemid 46572912)
20. D Cattan 2005 MEFV mutation carriers and diseases other than familial Mediterranean fever: Proved and non-proved associations; putative biological advantage Curr Drug Targets Inflamm Allergy 4 105 112 15720243 10.2174/1568010053622948 1:CAS:528:DC%2BD2MXktFSmtr0%3D (Pubitemid 40584860)
21. R Sundel I Szer 2002 Vasculitis in childhood Rheum Dis Clin N Am 28 625 665 10.1016/S0889-857X(02)00008-X
22. M Tekin F YalçInkaya N Tümer N Akar M MIsIrlIoǧlu N Çakar 2000 Clinical, laboratory and molecular characteristics of children with familial Mediterranean fever-associated vasculitis Acta Paediatr 89 177 182 10709887 10.1111/j.1651-2227.2000.tb01212.x 1:STN:280:DC%2BD3c7ntlWhsw%3D%3D (Pubitemid 30339589)
23. S Özen E Ben-Chetrit A Bakkaloǧlu, et al. 2001 Polyarteritis nodosa in patients with familial Mediterranean fever (FMF): a concomitant disease or a feature of FMF? Semin Arthritis Rheum 30 281 287 11182028 10.1053/sarh.2001.19958 (Pubitemid 32172733)
24. Michet CJ (1990) Epidemiology of vasculitis Rheum Dis Clin North Am 16:261-268 (Pubitemid 20380148)
25. S Akar Y Göktay B AkIncI, et al. 2005 A case of familial Mediterranean fever and polyarteritis nodosa complicated by spontaneous perirenal and subcapsular hepatic hemorrhage requiring multiple arterial embolizations Rheumatol Int 25 60 64 14712330 10.1007/s00296-003-0424-y
26. F YalçInkaya ZB Özçakar Ö Kasapçopur, et al. 2007 Prevalence of MEFV gene mutations in childhood polyarteritis nodosa J Pediatr 151 675 678 18035151 10.1016/j.jpeds.2007.04.062 (Pubitemid 350116122)
27. F Dedeoglu RP Sundel 2005 Vasculitis in children Pediatr Clin N Am 52 547 575 10.1016/j.pcl.2005.01.006 (Pubitemid 40463666)
28. M Tekin F YalçInkaya N Tümer, et al. 1999 Familial Mediterranean fever: renal involvement by diseases other than amyloid Nephrol Dial Transpl 14 475 479 10.1093/ndt/14.2.475 1:STN:280:DyaK1M7ms1Onuw%3D%3D (Pubitemid 29062821)
29. R Gershoni-Baruch Y Broza R Brik 2003 Prevalence and significance of mutations in the familial Mediterranean fever gene in Henoch-Schönlein purpura J Pediatr 143 658 661 14615741 10.1067/S0022-3476(03)00502-X 1:CAS:528:DC%2BD3sXovVWnsLY%3D (Pubitemid 37452797)
30. ZB Özçakar F YalçInkaya N Çakar, et al. 2008 MEFV Mutations Modify the Clinical Presentation of Henoch-Schönlein Purpura J Rheumatol 35 2427 2429 18843775 10.3899/jrheum.080405
31. G Cocco AY Gasparyan 2010 Behçet's disease: an insight from a cardiologist's point of view Open Cardiovasc Med J 23 63 70
32. M La Regina AY Gasparyan F Orlandinin D Prisco 2010 Behçet's disease as a model of venous thrombosis Open Cardiovasc Med J 23 71 77
33. E Ben-Chetrit R Cohen T Chajck-Shaul 2002 Familial Mediterranean fever and Behçet's disease-are they associated? J Rheumatol 29 530 534 11908568 (Pubitemid 34202823)
34. R Serrano MA Martinez A Andres JM Morales R Samartin 1998 Familial Mediterranean fever and acute myocardial infarction secondary to coronary vasculitis Histopathology 33 163 167 9762550 10.1046/j.1365-2559.1998.00462.x 1:STN:280:DyaK1cvjsFaqug%3D%3D (Pubitemid 28387027)
35. G Cocco 2008 Vasculitis, left bundle branch block, and Raynoud's phenomenon as a manifestation of familial mediterranean fever Arch Med Sci 4 460 464
36. Ş Yüksel L Ayvazyan AY Gasparyan 2010 Familial Mediterranean fever as an emerging clinical model of atherogenesis associated with low-grade inflammation Open Cardiovasc Med J 4 51 56 20360981
37. C Turesson LT Jacobsson EL Matteson 2008 Cardiovascular co-morbidity in rheumatic diseases Vasc Health Risk Manag 4 605 614 18827910
38. M YIldIz 2010 Arterial distensibility in chronic inflammatory rheumatic disorders Open Cardiovasc Med J 23 83 88
39. AY Gasparyan A Stavropoulos-Kalinoglou DP Mikhailidis TE Toms KM Douglas GD Kitas 2010 The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases Curr Vasc Pharmacol 8 437 449 19758114 10.2174/157016110791330852 1:CAS:528:DC%2BC3cXotlahsrg%3D
40. P Langevitz A Livneh L Neumann, et al. 2001 Prevalence of ischemic heart disease in patients with familial Mediterranean fever Isr Med Assoc J 3 9 12 11344818 1:STN:280:DC%2BD3M3ktVyluw%3D%3D (Pubitemid 34176872)
41. MP Grimaldi G Candore S Vasto, et al. 2006 Role of pyrin M694V A2080G9 allele in acute myocardial infarction and longevity: a study in the Sicilian population J Leukoc Biol 79 611 615 16387839 10.1189/jlb.0705416 1:CAS:528:DC%2BD28XisFKmsr8%3D (Pubitemid 44831237)
42. M ÇalIşkan H Güllü S YIlmaz, et al. 2007 Impaired coronary microvascular function in familial Mediterranean fever Atherosclerosis 195 e161 e167 17673217 10.1016/j.atherosclerosis.2007.06.014 (Pubitemid 350087982)
43. A Akdoǧan M Çalgüneri B Yavuz, et al. 2006 Are familial Mediterranean fever (FMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in FMF J Am Coll Cardiol 48 2351 2353 17161270 10.1016/j.jacc.2006.09.013 (Pubitemid 44855439)
44. S Uǧurlu E Seyahi F Çetinkaya F ÖzbakIr H BalcI H Özdoǧan 2009 Intima-media thickening in patients with familial Mediterranean fever Rheumatology 48 911 915 19478036 10.1093/rheumatology/kep131
45. H Peru B Altun M Doǧan F Kara A ElmacI B Oran 2008 The evaluation of carotid intima-media thickness in children with familial Mediterranean fever Clin Rheumatol 27 689 694 17926078 10.1007/s10067-007-0764-1 (Pubitemid 351650029)
46. Y Bilginer F ÖzaltIn C Başaran, et al. 2008 Evaluation of intima media thickness of the common and internal carotid arteries with inflammatoy markers in familial Mediterranean fever as possible predictors for atherosclerosis Rheumatol Int 28 1211 1216 18500463 10.1007/s00296-008-0605-9 1:CAS:528:DC%2BD1cXhtV2jurnN
47. E Coban H Adanir 2008 Platelet activation in patients with familial Mediterranean fever Platelets 19 405 408 18925507 10.1080/09537100802187121 1:CAS:528:DC%2BD1cXht1Glu7nI
48. M YIldIz S MasatlIoglu P Seymen E Aytac B Sahin HO Seymen 2006 The carotid-femoral (aortic) pulse wave velocity as a marker of arterial stiffness in familial Mediterranean fever Can J Cardiol 22 1127 1131 17102830 10.1016/S0828-282X(06)70949-7 (Pubitemid 44932379)
49. I SarI O Karaoǧlu G Can, et al. 2007 Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever Clin Rheumatol 26 1467 1473 17242867 10.1007/s10067-006-0529-2 (Pubitemid 47193563)
50. I Sari Ö ArIcan G Can, et al. 2008 Assessment of aortic stiffness and ventricular functions in familial Mediterranean fever Anodolu Kardiyol Derg 8 271 278
51. Y Tavil MA Öztürk K Üreten, et al. 2008 Assessment of aortic wall stiffness in patients with familial Mediterranean fever Joint Bone Spine 75 280 285 18375166 10.1016/j.jbspin.2007.05.021
52. M Rozenbaum JE Naschitz M Yudashkin, et al. 2004 Cardiovascular reactivity score for the assessment of dysautonomia in familial Mediterranean fever Rheumatol Int 24 147 152 13680148 10.1007/s00296-003-0344-x (Pubitemid 38797627)
53. M Tekin F YalçInkaya N Tümer N Çakar H Koçak 1999 Familial Mediterranean fever and acute rheumatic fever: a pathogenic relationship? Clin Rheumatol 18 446 449 10638768 10.1007/s100670050136 1:STN:280:DC%2BD3c7gt1ejtA%3D%3D (Pubitemid 30014162)
54. E Tutar E Tutar N Akar, et al. 2002 Familial Mediterranean fever gene (MEFV) mutations in patients with rheumatic heart disease Heart 87 568 569 12010946 10.1136/heart.87.6.568 1:STN:280:DC%2BD383ntFOksg%3D%3D (Pubitemid 34547988)
55. F YalçInkaya E İnce T Uçar, et al. 2002 Antistreptococcal response is exaggerated in children with familial Mediterranean fever Clin Rheumatol 1 378 381 10.1007/s100670200101
56. J Gafni M Ravid E Sohar 1968 The role of amyloidosis in familial Mediterranean fever. A population study Isr J Med 4 995 999 1:STN:280: DyaF1M7jtlylsA%3D%3D
57. Fl Özer E Kaplaman S Zileli 1971 Familial Mediterranean fever in Turkey. A report of twenty cases Am J Med 50 336 339 5553952 10.1016/0002-9343(71)90222-1
58. A Livneh P Langevitz D Zemer, et al. 1996 The changing face of familial Mediterranean fever Semin Arthritis Rheum 26 612 627 8989806 10.1016/S0049-0172(96)80012-6 1:STN:280:DyaK2s7ktlOqtw%3D%3D (Pubitemid 27024198)
59. E Ben-Chetrit R Backenroth 2001 Amyloidosis induced end stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene Ann Rheum Dis 60 146 149 11156548 10.1136/ard.60.2.146 1:CAS:528:DC%2BD3MXhs1SktrY%3D (Pubitemid 32102206)
60. C Cazeneuve H Ajrapetyan S Papin, et al. 2000 Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever Am J Hum Genet 67 1136 1143 11017802 1:CAS:528:DC%2BD3cXot1antbk%3D
61. HJ Lachman HJB Goodman JA Gilbertson, et al. 2007 Natural history and outcome in systemic AA amyloidosis N Engl J Med 356 2361 2371 10.1056/NEJMoa070265 (Pubitemid 46883770)
62. SW Dubrey K Cha R Simms M Skinner RH Falk 1996 Electrocardiography and Doppler echocardiography in secondary (AA) amyloidosis Am J Cardiol 77 313 315 8607418 10.1016/S0002-9149(97)89403-9 1:STN:280:DyaK287ptVarsg%3D%3D (Pubitemid 26059307)
63. JPM Hamer S Janssen MH van Rijswijk KI Lie 1992 Amyloid cardiomyopathy in systemic non-hereditary amyloidosis: clinical, echocardiographic and electrocardiographic findings in 30 patients with AA and 24 patients with AL amyloidosis Eur Heart J 13 623 627 1618203 1:STN:280:DyaK38zhs1SgtQ%3D%3D
64. A Gasparyan 2008 Echocardiographic features of cardiac involvement in familial Mediterranean fever Clin Exp Rheumatol 26 192
65. A YIldIz V Akkaya I KIlIçaslan A Türkmen B Görçin D AtIlgan 2001 Cardiac and intestinal amyloidosis in a renal transplant recipient with familial Mediterranean fever J Nephrol 14 125 127 11411014 (Pubitemid 32433019)
66. A Türkmen A YIldIz R Erkoç, et al. 1998 Transplantation in renal amyloidosis Clin Transplant 12 375 378 9787944 (Pubitemid 28446124)
67. S Tuǧlular F YalçInkaya S Paydaş, et al. 2002 A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey Nephrol Dial Transplant 17 2003 2005 12401861 10.1093/ndt/17.11.2003 (Pubitemid 35277102)
68. T Kallinich D Haffner T Niehues, et al. 2007 Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement Pediatrics 119 e474 e483 17242135 10.1542/peds.2006-1434 (Pubitemid 46397797)
69. M Imazio M Bobbio E Cecchi, et al. 2005 Colchicine as first choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial Arch Intern Med 165 1987 1991 16186468 10.1001/archinte.165.17.1987 1:CAS:528:DC%2BD2MXhtFeltr7F (Pubitemid 41362621)
70. N Çakar F YalçInkaya N Özkaya, et al. 2001 FMF associated amyloidosis in childhood: clinical features, course and outcome Clin Exp Rheum 19 Suppl 124 63 67
71. ZB Ozçakar F Yalçinkaya S Yüksel B Acar D Gökmen M Ekim 2006 Possible effect of subclinical inflammation on daily life in familial Mediterranean fever Clin Rheumatol 25 149 152 16172947 10.1007/s10067-005-1148-z (Pubitemid 43372309)
72. ZB Ozçakar G Kadioǧlu Z Siklar, et al. 2010 The effect of colchicine on physical growth in children with familial mediterranean fever Eur J Pediatr 169 825 828 20016916 10.1007/s00431-009-1120-z
73. M Nidorf PL Thompson 2007 Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease Am J Cardiol 99 805 807 17350370 10.1016/j.amjcard.2006.10.039 1:CAS:528:DC%2BD2sXisl2qsbc%3D (Pubitemid 46371398)
74. M Justiniano S Dold LR Espinoza 2007 Rapid onset of muscle weakness (rhabdomyolysis) associated with the combined use of simvastatin and colchicine J Clin Rheumatol 13 266 268 17921794 10.1097/RHU.0b013e318156d977 (Pubitemid 47549164)